Join this webinar to hear from Concarlo’s CEO and CSO Dr. Stacy Blain and COO LisaMarie Casey as they discuss the science behind a remarkable breakthrough in the treatment of metastatic cancers.
RESI Innovator’s Pitch Challenge Winner
Concarlo wins the Innovator’s Pitch Challenge at RESI Jan 2021!
Targeting p27Kip1 to Treat Drug-Resistance Cancer
Stacy Blain, PhD, Founder, CSO and CEO
2019 Social Enterprise Conference
Stacy Blain was a panelist at Columbia University’s Social Enterprise Conference.
WE NYC Women in Tech Conference
Stacy Blain was a panelist at WE NYC’s annual summit, Female Founders Disrupting HealthTech, at the New York Genome Center.
Click here to download Stacy’s article: Targeting p27 tyrosine phosphorylation as a modality to inhibit CDK4 and CDK2 and cause cell cycle arrest in breast cancer cells.